TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer
Aditya Bardia,Sara Hurvitz,Michael F. Press,Lisa S. Wang,Nicholas P. McAndrew,David Chan, Vu Phan,Deborah Villa, Merry L. Tetef, Erin Chamberlain, Nihal Abdulla, Thomas Lomis,Laura M. Spring, Steven Applebaum,Shaker Dakhil,Brian DiCarlo,David D. Kim, Evangelia Kirimis, William E. Lawler, Aashini K. Master,Kelly McCann, Edwin Hayashi, Christine Kivork, James Chauv CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
